
Moderna has requested for emergency use authorisation (EUA) for its Covid-19 vaccine for children ages six months through five years to the US Food and Drug Administration, Politico first reported first late on Wednesday night.
“We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," said Stéphane Bancel, Chief Executive Officer of Moderna, in a press release issued on Thursday.